KRYS vs VAL
As of Sep 20, 2026, Krystal Biotech (KRYS) scores 5.5/10 and Valaris (VAL) 4.6/10 on AlphaStocks' five-model composite, so KRYS scores higher. KRYS trades 54% above its model fair value.
KRYS
Krystal Biotech, Inc.
5.5
Consider Buy
$336.82
VAL
Valaris Ltd
4.6
Weak
$83.77
KRYS vs VAL: Which is the Better Investment?
Krystal Biotech, Inc. (KRYS) scores 5.5/10 while Valaris Ltd (VAL) scores 4.6/10 on AlphaStocks' composite model. Krystal Biotech, Inc. has the higher composite rating of Consider Buy. On a P/E basis, Valaris Ltd trades at 6.0x, making it the more attractively priced of the two.
This comparison is algorithmically generated and is not financial advice.
| Metric | KRYS | VAL |
|---|---|---|
| Scores & Fundamentals | ||
| Composite Score | 5.5/10▲ | 4.6/10 |
| Rating | Consider Buy▲ | Weak |
| Price | $336.82 | $83.77 |
| P/E Ratio | 49.3 | 6.0▲ |
| ROE | 17.2% | 35.0%▲ |
| Market Cap | $10B | $6B |
| Fair Value | $218.10 | — |
| Dividend Yield | — | — |
| Sector Rank | #75 of 168▲ | #37 of 80 |
| Model Verdicts | ||
| Piotroski | Attractive | Strong▲ |
| Buffett | Neutral | Attractive▲ |
| Graham | Caution | Neutral▲ |
| Lynch | Limited Data | Neutral▲ |
| Greenblatt | Limited Data | Attractive▲ |
Related comparisons
KRYS vs VAL: Which Stock Scores Higher?
Krystal Biotech, Inc. (KRYS) is in the Health Care sector; Valaris Ltd (VAL) is in Energy. KRYS currently leads with a composite score of 5.5/10 (Consider Buy) compared to VAL's 4.6/10 (Weak).
The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.
This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer